Plasma apixaban levels in Chinese patients with chronic kidney disease—Relationship with renal function and bleeding complications

Introduction: Accumulation of apixaban in plasma is a major concern in patients with chronic kidney disease (CKD). Studies that investigated plasma apixaban level in CKD patients and its association with clinically significant events are scarce. Methods: Patients with CKD Stage 1–4 who were taking a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sin, Chun-fung, Wong, Ka-ping, Wong, Tsz-fu, Siu, Chung-wah, Yap, Desmond Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772439/
https://www.ncbi.nlm.nih.gov/pubmed/36569289
http://dx.doi.org/10.3389/fphar.2022.928401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772439/
https://www.ncbi.nlm.nih.gov/pubmed/36569289
http://dx.doi.org/10.3389/fphar.2022.928401

Ejemplares similares